Review of current indications for combined very high fluence collagen cross-linking and laser in situ keratomileusis surgery.

Anastasios John Kanellopoulos, Gregory J Pamel

Journal: Indian journal of ophthalmology 2014;61(8):430-2

PMID: 23925331

Free Full Text on PubMed Central View on PubMed

Abstract

In this brief review we will discuss the reasoning and evolution of our current use of combined very high-fluence collagen crosslinking and laser in situ keratomileusis. Several presentations and pertinent publications are reviewed, along with the key steps of the enhanced LASIK procedure. Long term outcome data support the safety and efficacy of LASIK Xtra in stabilizing myopic but also hyperopic LASIK results.In conclusion, we have compelling evidence that LASIK Xtra is a safe and effective adjunct.

Address: New York University School of Medicine, New York, USA.

DOI: 10.4103/0301-4738.116074

Link outs

Free resources

Full Text Sources:

Other Literature Sources:

https://scite.ai/reports/23925331

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Collagen, Combined Modality Therapy, Corneal Stroma, Cross-Linking Reagents, Humans, Keratoconus, Keratomileusis, Laser In Situ, Photochemotherapy, Photosensitizing Agents, Riboflavin, Ultraviolet Rays